Toxicology and Pharmacology of the Lanthanides

  • C. H. Evans
Part of the Biochemistry of the Elements book series (BOTE, volume 8)


Broadly speaking, lanthanides interfere with normal metabolism in one of two general ways. The first is through specific biochemical interaction producing, as we shall see, a variety of toxic and pharmacologic sequelae. The second concerns the damage inflicted by radioactive lanthanides. Although the latter is an important matter related to such topical concerns as the safety of nuclear power plants and the dangers of nuclear weapons, it is not, in itself, a field of inquiry that is unique to the lanthanides. Rather, it belongs to the larger arena of radiation biology and biochemistry, a discussion of which lies outside the scope of this book. For this reason, the radiotoxicity of lanthanides is not given more than a passing mention in this chapter. Instead, we shall concentrate on the metabolic and physiological perturbations produced by nonradioactive lanthanides.


Rare Earth Fatty Liver Rare Earth Metal Light Lanthanide Heavy Lanthanide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abaas, S., 1984. Induction of aggregation in Streptococcus mit is by certain ions, Acta Pathol. Microbiol. Immunol. Scand. 92:253–259.Google Scholar
  2. Abel, M., and Talbot, R. B., 1967. Gadolinium oxide inhalation by guinea pigs: a correlative functional and histopathologic study, J. Pharmacol. Exp. Ther. 157:207–213.PubMedGoogle Scholar
  3. Abramczuk, J. W., 1985. The effects of lanthanum chloride on pregnancy in mice and on preimplantation mouse embryos in vitro, Toxicology 34:315–320.PubMedGoogle Scholar
  4. Ajazzi-Mancini, M., 1926. Cited in Haley (1965).Google Scholar
  5. Anon, 1988. RE in fresh-water fishery, China Rare Earth Info. 9:3.Google Scholar
  6. Arkhangelskaya, L.N., and Spasskii, S.S., 1967. Cited in Haley (1979).Google Scholar
  7. Arvela, P., 1973. The in vitro effects of lanthanons on lipid peroxidation and drug metabolism in rat, Acta Physiol. Scand. Suppl. 396:234.Google Scholar
  8. Arvela, P., 1974. The effect of α-tocopherol on cerium induced changes in drug and lipid metabolism of rat, Experientia 30:1061–1062.PubMedGoogle Scholar
  9. Arvela, P., 1979. Toxicity of rare-earths, Prog. Pharmacol. 2:71–114.Google Scholar
  10. Arvela, P., and Karki, N.T., 1971. Effect of cerium on drug metabolizing activity in rat liver, Experientia 27:1189–1190.PubMedGoogle Scholar
  11. Arvela, P., and Karki, N.T., 1972. Effect of phenobarbital pretreatment on cerium induced impairment of drug metabolism in rat liver, Acta Pharmacol. Toxicol. 31:380–386.Google Scholar
  12. Arvela, P., Grajewski, O., Von Lehmann, B., and Oberdisse, E., 1977. Effect of lanthanons on substrate-induced difference spectra in rat liver microsomes, Experientia 32:491–493.Google Scholar
  13. Arvela, P., Von Lehmann, B., Grajewski, O., and Oberdisse, E., 1980a. Effect of praseodymium on drug metabolism in rat liver smooth and rough endoplasmic reticulum, Experientia 36:860–861.PubMedGoogle Scholar
  14. Arvela, P., Oberdisse, E., Merker, H. J., Grajewski, O., and Von Lehmann, B., 1980b. The influence of lanthanons on morphology and function of rat exocrine pancreas in vivo, Pathol. Res. Pract. 169:330–340.PubMedGoogle Scholar
  15. Arvela, P., Reinila, M., and Pelkonen, O., 1981. Effects of phenobarbital and β-naphtho- flavone on cerium induced biochemical changes in rat serum, Toxicol. Lett. 8:213–216.PubMedGoogle Scholar
  16. Baehr, G., and Wessler, H., 1909. The use of cerium oxalate for the relief of vomiting: an experimental study of the effects of some salts of cerium, lanthanum, praseodymium, neodymium and thorium, Arch. Intern. Med. 2:517–531.Google Scholar
  17. Bahadur, K., and Tripathi, P., 1978. Investigation of cerium and yttrium ions’ effects on microbial nitrogen fixation and determination of inhibition, Zentralbl. Bakteriol. II Abt. 133:628–631.Google Scholar
  18. Bahadur, K., Prakash, S., and Jyotishmati, U., 1978. Microbial fixation of nitrogen in presence of lanthanum sulphate with sodium molybdate, Zentralbl. Bakteriol. II Abt. 133:632–637.Google Scholar
  19. Ball, R. A., and Van Gelder, G., 1966. Chronic toxicity of gadolinium oxide for mice following exposure by inhalation, Arch. Environ. Health 13:601–608.PubMedGoogle Scholar
  20. Ball, R.A., Van Gelder, G., and Green, J.W., 1970. Neoplastic sequelae following subcutaneous implantation of mice with rare earth metals, Proc. Soc. Exp. Biol. Med. 135: 426–430.PubMedGoogle Scholar
  21. Basu, A., Haldar, S., Chakrabarty, K., Santra, M., and Chatterje, G.C., 1984. Effect of cysteine supplementation on lanthanum chloride induced alterations in the antioxidant defense system of chick liver, Indian J. Exp. Biol. 22:432–434.PubMedGoogle Scholar
  22. Beaser, S.B., Segel, A., and Vandam, L., 1942. The anticoagulant effects in rabbits and man of the intravenous injection of salts of the rare earths, J. Clin. Invest. 21:447–453.PubMedCentralPubMedGoogle Scholar
  23. Beller, F. K., and Mammen, E., 1956. Der angriffspunkt der seltenen erden neodym in Gerinnungssystem, Arch. Gynaek. 187:319–336.Google Scholar
  24. Bjondahl, K., Mottonen, M., and Nieminen, L., 1973. The effect of spironolactone on acute toxicity and liver damage in mice induced by cerium chloride, Experientia 29:685–687.PubMedGoogle Scholar
  25. Bjondahl, K., Isomaa, B., and Nieminen, L., 1974. Effect of pretreatment with phenobarbital and spironolactone on 144Ce levels in blood, liver, urine and faeces at various time periods, Biochem. Pharmacol. 23:1509–1518.PubMedGoogle Scholar
  26. Bjorkman, S.E., and Horsfall, F.L., 1948. The production of a persistent alteration in influenza virus by lanthanum or ultraviolet irradiation, J. Exp. Med. 88:445–461.PubMedCentralPubMedGoogle Scholar
  27. Borowitz, J. L., 1972. Effect of lanthanum on catecholamine release from adrenal medulla, Life Sci. 11:959–964.Google Scholar
  28. Boyd, K. S., Melnykovych, G., and Fiskin, A. M., 1976. A replica technique for visualizing the distribution of lanthanum-binding sites over HeLa surfaces, Cytobiology 14:91–101.Google Scholar
  29. Brooks, M.M., 1921. Comparative studies on respiration. XIV. Antagonistic action of lanthanum as related to respiration, J. Gen. Physiol. 3:337–342.PubMedCentralPubMedGoogle Scholar
  30. Bruce, D. W., Hietbrink, B. E., and DuBois, K. P., 1963. The acute mammalian toxicity of rare earth nitrates and oxides, Toxicol. Appl. Pharmacol. 5:750–759.PubMedGoogle Scholar
  31. Bulman, R. A., and Stretton, R. J., 1975. Effect of the lanthanides lanthanum and neodymium on the heat resistance of Bacillus cereus spores, Microbios 12:167–174.PubMedGoogle Scholar
  32. Burkes, S., and McCleskey, C.S., 1947. The bacteriostatic activity of cerium, lanthanum and thallium, J. Bacteriol. 54:417–424.PubMedCentralPubMedGoogle Scholar
  33. Burnett, K.R., Wolf, G.L., Schumacher, H.R., and Goldstein, E.J., 1985. Gadolinium oxide: a prototype agent for contrast enhanced imaging of the liver and spleen with magnetic resonance, Magn. Reson. Imaging 3:65–71.PubMedGoogle Scholar
  34. Caillé, J. M., Lemanceau, B., and Bonnemari, B., 1983. Gadolinium as a contrast agent for NMR, Am. J. Nucl. Med. 4:1041–1042.Google Scholar
  35. Cassone, A., and Garaci, E., 1974. Lanthanum staining of the intermediate region of the cell wall in Escherichia coli, Experientia 30:1230–1232.Google Scholar
  36. Castillo, M.R., and Bibby, B.G., 1973. Trace element effects on enamel pigmentation, incisor growth and molar morphology in rats, Arch. Oral Biol. 18:629–635.Google Scholar
  37. Cochran, K. W., Doull, J., Mazur, M., and DuBois, K. P., 1950. Acute toxicity of zirconium, columbium, strontium, lanthanum, cesium, tantalum and yttrium, Arch. Ind. Hyg. Occup. Med. 1:637–650.PubMedGoogle Scholar
  38. D’Agostino, R. B., Lown, B.A., Morganti, J.B., and Massaro, E.J., 1982. Effects of in utero or suckling exposure to cerium (citrate) on the postnatal development of the mouse, J. Toxicol. Environ. Health 1:449–458.Google Scholar
  39. Davison, F.C., and Ramsey, F. K., 1965. Cited in Haley (1979).Google Scholar
  40. Dorovini-Zis, K., Sato, M., Goping, G., Rapoport, S., and Brightman, M., 1983. Ionic lanthanum passage across cerebral endothelium exposed to hyperosmotic arabinose, Acta Neuropathol. 60:49–60.PubMedGoogle Scholar
  41. Drossbach, G. P., 1897. Über den Einfluss der Elemente der Cerund Zircon gruppe auf das Wachstum von Bakterien, Zentralbl. Bakteriol. Parasitenkd. Abt. 1 Orig. 21:57–58.Google Scholar
  42. Drouven, B. J., and Evans, C. H., 1986. Collagen fibrillogenesis in the presence of lanthanides, J. Biol. Chem. 261:11792–11797.PubMedGoogle Scholar
  43. Dryfuss, B.J., and Wolf, C.G.L., 1906. The physiological action of lanthanum, praseodymium and neodymium, Am. J. Physiol. 16:314–323.Google Scholar
  44. Ecker, D. J., Butt, T. R., Sternberg, E. J., Neeper, M.P., Debouck, C., Gorman, J. A., and Crooke, S. T., 1986. Yeast metallothionein function in metal ion detoxification, J. Biol. Chem. 261:16895–16900.PubMedGoogle Scholar
  45. Eisenberg, P., 1919. Untersuchungen über spezifische Desinfektionsvorgange. II. Über die Wirkung von Salzen und Ionen auf Bakterien, Zentralbl. Bakteriol. Parasitenkd. Abt. 1 Orig. 82:69–208.Google Scholar
  46. Evans, W. H., 1913. The influence of the carbonates of the rare earths (cerium, lanthanum, yttrium) on growth and cell-division in hyacinths, Biochem. J. 7:349–355.PubMedCentralPubMedGoogle Scholar
  47. Ewaldsson, E., and Magnusson, G., 1964a. Distribution of radiocerium and radiopromethium in mice, Acta Radiol. Ther. Phys. Biol. 2:65–72.PubMedGoogle Scholar
  48. Ewaldsson, E., and Magnusson, G., 1964b. Distribution of radioterbium, radioholmium and radioyttrium in mice, Acta Radiol. Ther. Phys. Biol. 2:121–128.PubMedGoogle Scholar
  49. Farkas, B., and Karacsonyi, G., 1985. The effect of ketoconazole on Candida albicans infection following depression of the reticuloendothelial activity with gadolinium chloride, Mykosen 28:338–341.PubMedGoogle Scholar
  50. Fischler, F., and Roeckl, K. W., 1938. Über experimentelle Beeinflussung er Leberfunktionen und der anatomischen Leberstruktur durch Einwirkung seltaer Erden, Naunyn-Schmiedeberg’s Arch. Exp. Pathol. Pharmacol. 189:4–21.Google Scholar
  51. Fleisch, H., and Neuman, W. F., 1961. Mechanisms of calcification: role of collagen, polyphosphates and phosphatase, Am. J. Physiol. 200:1296–1300.Google Scholar
  52. Gabbiani, G., and Tuchweber, B., 1965. Studies on the mechanism of experimental soft tissue calcification, Can. J. Physiol. Pharmacol. 43:177–183.PubMedGoogle Scholar
  53. Gabbiani, G., and Tuchweber, B., 1970. Studies on the mechanism of calcergy, Clin. Orthop. 69:66–74.PubMedGoogle Scholar
  54. Gabbiani, G., Jacqmin, M.L., and Richard, R. M., 1966. Soft-tissue calcification induced by rare earth metals and its prevention by sodium pyrophosphate, Br. J. Pharmacol. 27:1–9.Google Scholar
  55. Gale, T. F., 1975. The embryotoxicity of ytterbium chloride in golden hamsters, Teratology 11:289–296.PubMedGoogle Scholar
  56. Garrett, I. R., and McClure, J., 1981. Lanthanide-induced calcergy, J. Pathol. 135:267–275.PubMedGoogle Scholar
  57. Gehrcke, E., Lau, E., and Meinhart, O., 1939. The rare earths and the nervous system, Z. Ges. Naturwiss. 5:106–107.Google Scholar
  58. Gerhardsson, L., Wester, P.O., Nordberg, G. F., and Brune, D., 1984. Chromium cobalt and lanthanum in lung, liver and kidney tissue from deceased smelter workers, Sci. Total Environ. 37:233–246.PubMedGoogle Scholar
  59. Glenn, J. L., Tischer, K., and Stein, A., 1962. Rare-earth fatty liver. I. Octanoate oxidation and energy production, Biochim. Biophys. Acta 62:35–40.PubMedGoogle Scholar
  60. Godin, D. V., and Frohlich, J., 1981. Erythrocyte alterations in praseodymium-induced lecithin:cholesterol acyltransferase (LCAT) deficiency in the rat: comparison with familial LCAT deficiency in man, Res. Commun. Chem. Pathol. Pharmacol. 31:555–556.PubMedGoogle Scholar
  61. Graca, J.G., Garst, E.L., and Lowry, W. E., 1957. Comparative toxicity studies of stable rare earth compounds. I. Effect of citrate complexing on stable rare earth chloride toxicity, A.M.A. Arch. Ind. Health 15:9–14.Google Scholar
  62. Graca, J.G., Davison, F. C., and Feavel, J.B., 1962. Comparative toxicity of stable rare earth compounds. II. Effect of citrate and edetate complexing on acute toxicity in mice and guinea pigs, Arch. Environ. Health 5:437–444.PubMedGoogle Scholar
  63. Graca, J.G., Davison, F. C., and Feavel, J. B., 1964. Comparative toxicity of stable rare earth compounds. III. Acute toxicity of intravenous injections of chlorides and chelates in dogs, Arch. Environ. Health 8:555–564.PubMedGoogle Scholar
  64. Grajewski, O., Von Lehmann, B., Arntz, H.R., Arvela, P., and Oberdisse, E., 1977. Alterations in rat serum lipoproteins and lecithin-cholesterol-acyltransferase activity in praseodymium-induced liver damage, Naunyn-Schmiedeberg’s Arch. Pharmacol. 301: 65–73.Google Scholar
  65. Grant, W.M., and Kern, H.L., 1956. Cations and the cornea. Toxicity of metals to the stroma, Am. J. Ophthalmol. 42:167–181.PubMedGoogle Scholar
  66. Graul, E. H., and Hundeshagen, H., 1959. Investigations of radioyttrium (Y90) metabolism. Studies on organ-distribution with special regard to the radioautographic method of demonstration and to paper electrophoresis under various experimental conditions, Int. J. Appl. Radiat. Isotop. 5:243–252.Google Scholar
  67. Guida, G., 1930. Cited in Haley (1965).Google Scholar
  68. Guo, B., 1985. Present and future of rare earth research in Chinese agriculture, J. Chin. Rare Earth Soc. 3:89–94.Google Scholar
  69. Haley, T. J., 1965. Pharmacology and toxicology of the rare earth elements, J. Pharm. Sci. 54:663–670.PubMedGoogle Scholar
  70. Haley, T. J., 1979. Toxicity, in Handbook on the Physics and Chemistry of Rare Earths (K. A. Gschneidner and L. R. Eyring, eds.), Vol. 4, North-Holland, Amsterdam, pp. 553–585.Google Scholar
  71. Haley, T. J., and Upham, H.C., 1963. Skin reaction to intradermal injection of rare earths, Nature 200:271.PubMedGoogle Scholar
  72. Haley, T. J., Raymond, K., Komesu, N., and Upham, H.C., 1961. Toxicological and pharmacological effects of gadolinium and samarium chlorides, Br. J. Pharmacol. 17:526–532.Google Scholar
  73. Haley, T.J., Komesu, N., Flesher, A.M., Mavis, L., Cawthorne, J., and Upham, H.C., 1963. Pharmacology and toxicology of terbium, thulium and ytterbium chlorides, Toxicol. Appl. Pharmacol. 5:427–436.PubMedGoogle Scholar
  74. Haley, T.J., Komesu, N., Efros, M., Koste, L., and Upham, H.C., 1964. Pharmacology and toxicology of lutetium chloride, J. Pharm. Sci. 53:1186–1188.PubMedGoogle Scholar
  75. Hara, S., 1923. Beitrage zur Pharmakologie der Seltenen Erdmetalle. I. Mitteilung: Über das cerium, Naunyn-Schmiedeberg’s Arch. Exp. Pathol. Pharmacol. 100:217–253.Google Scholar
  76. Harris, R.A., Iwamoto, E.T., Loh, H.H., and Way, E.L., 1975. Analgetic effects of lanthanum: cross-tolerance with morphine, Brain Res. 100:221–225.PubMedGoogle Scholar
  77. Harris, R. A., Loh, H. H., and Way, E. L., 1976. Antinociceptive effects of lanthanum and cerium in nontolerant and morphine tolerant-dependent animals, J. Pharmacol. Exp. Ther. 196:288–297.PubMedGoogle Scholar
  78. Havron, A., Davis, M.A., Seller, S.E., Paskins-Hurlburt, A. J., and Hessel, S.J., 1980. Heavy metal particulate contrast materials for computed tomography of the liver, J. Comput. Assist. Tomogr. 4:642–648.PubMedGoogle Scholar
  79. Heuck, F., and Hoschek, R., 1968. Cer-pneumoconiosis, Am. J. Radiol. 104:777–783.Google Scholar
  80. Hunter, R. B., and Walker, W., 1956. Anticoagulant action of neodymium 3-sulfo-isonicotinate, Nature 178:47.PubMedGoogle Scholar
  81. Husain, M.H., Dick, J. A., and Kaplan, Y.S., 1980. Rare earth pneumoconiosis, J. Soc. Occup. Med. 30:15–19.PubMedGoogle Scholar
  82. Husztik, E., Lazar, G., and Parducz, A., 1980. Electron microscopic study of Kupffer-cell phagocytosis blockage induced by gadolinium chloride, Br. J. Exp. Pathol. 61:624–630.PubMedCentralPubMedGoogle Scholar
  83. Hutcheson, D. P., Gray, D. H., Verugopal, B., and Luckey, T. D., 1975. Nutritional safety of heavy metals in mice, J. Nutr. 105:670–675.PubMedGoogle Scholar
  84. Iwamoto, E. T., Harris, R. A., Loh, H. H., and Way, E. L., 1978. Antinociceptive responses after microinjection of morphine or lanthanum in discrete rat brain sites, J. Pharmacol. Exp. Ther. 206:46–55.PubMedGoogle Scholar
  85. Johansson, O., Perrault, G., Savoie, L., and Tuchweber, B., 1968. Action of various metallic chlorides on calcaemia and phosphataemia, Br. J. Pharmacol. Chemother. 33:91–97.Google Scholar
  86. Kadas, I., Tanka, D., Keller, M., and Jobst, K., 1974a. Enzyme-histochemical and biochemical study of liver injury induced by lanthanum trichloride, Acta Morphol. Acad. Sci. Hung. 22:35–45.PubMedGoogle Scholar
  87. Kadas, I., Lapis, K., and Jobst, K., 1974b. Electron microscopic studies of liver changes induced by lanthanum trichloride, Acta Morphol. Acad. Sci. Hung. 22:343–357.PubMedGoogle Scholar
  88. Keresztes-Nagy, P., and Rosenfeld, J.P., 1981. Naloxone-reversible duplication by lanthanum of differential opiate analgesic effects on orofacial versus lower body versus central nociception, Brain Res. 208:234–239.PubMedGoogle Scholar
  89. Kikhachev, Yu. P., Lyarskii, P.P., and Elovskaya, L.T., 1972. Cited in Haley (1979).Google Scholar
  90. Kyker, G.C., and Cress, E. A., 1957. Acute toxicity of yttrium, lanthanum and other rare earths, A.M.A. Arch. Ind. Health 16:475–479.Google Scholar
  91. Kyker, G. C., Cress, E. A., Sivaramakrishnan, V. M., Steffee, C. H., and Stewart, M., 1957. Fatty infiltration due to rare earths, Fed. Proc. 16:207.Google Scholar
  92. Laszlo, D., Ekstein, D. M., Lewin, R., and Stern, K. G., 1952. Biological studies on stable and radioactive rare earth compounds. I. On the distribution of lanthanum in the mammalian organism, J. Natl. Cancer Inst. 13:559–573.PubMedGoogle Scholar
  93. Lazar, G., 1973a. Effect of reticuloendothelial stimulation and depression on rare earth metal chloride-induced splenic calcification and fatty degeneration of the liver, Exper-ientia 29:818–819.Google Scholar
  94. Lazar, G., 1973b. The reticuloendothelial-blocking effect of rare earth metals in rats, J. Reticuloendothel. Soc. 13:231–237.PubMedGoogle Scholar
  95. Lazar, G., Husztik, E., and Ribarszki, S., 1985. Reticuloendothelial blockade induced by gadolinium chloride. Effect on humoral immune response and anaphylaxis, in Macrophage Biology (S. Reichard and M. Kojima, eds.), Alan Liss, New York, pp. 571–582.Google Scholar
  96. Lombardi, B., and Recknagel, R.O., 1962. Interference with secretion of triglycerides by the liver as a common factor in toxic liver injury, Am. J. Pathol. 40:571–586.PubMedCentralPubMedGoogle Scholar
  97. MacDonald, N. W., Nusbaum, R. E., Alexander, G. V., Ezmirnan, F., Spain, P., and Rounds, D.E., 1952. The skeletal deposition of yttrium, J. Biol. Chem. 195:837–842.PubMedGoogle Scholar
  98. Magnusson, G., 1963. The behavior of certain lanthanons in rats, Acta Pharmacol. Toxicol., Suppl. 3 20:1–95.Google Scholar
  99. Marciniak, M., and Baltrukiewicz, Z., 1977. Serum ornithine carbonoyltransferase (OCT) in rats poisoned with lanthanum, cerium and praseodymium, Acta Physiol. Pol. 28: 589–594.PubMedGoogle Scholar
  100. Maxwell, L. C., Bischoff, F., and Ottery, E. M., 1931. Studies in cancer chemotherapy. X. The effect of thorium, cerium, erbium, yttrium, didymium, praseodymium, manganese and lead upon transplantable rat tumors, J. Pharmacol. Exp. Ther. 43:61–70.Google Scholar
  101. McClure, J., 1980. The production of heterotropic calcification by certain chemical salts, J. Pathol. 131:21–33.PubMedGoogle Scholar
  102. Mezentseva, N. V., 1967. Cited in Haley (1979).Google Scholar
  103. Miller, L. P., 1959. Factors influencing the uptake and toxicity of fungicides, Trans. N.Y. Acad. Sci. 21:442–445.Google Scholar
  104. Miller, L.P., and McCallan, S.E. A., 1957. Toxic action of metal ions to fungus spores, J. Agrie. Food Chem. 5:116–122.Google Scholar
  105. Mogilevskaya, O. Ya., and Roshchina, T. A., 1967. Cited in Haley (1979).Google Scholar
  106. Morganti, J. B., Lown, B. A., Chapín, E., D’Agostino, R. B., and Monteverde, E. J., 1980. Effects of acute exposure to cerium nitrate on selected measures of activity, learning and social behavior of the mouse, Gen. Pharmacol. 11:369–373.PubMedGoogle Scholar
  107. Mori, I., 1931. Pharmakologische Untersuchungen über die seltenen Erdmetaila Lanthan, Cerium, Praseodym und Neodym, Jpn. J. Med. Sci. 5:13–14.Google Scholar
  108. Muroma, A., 1958. Studies on the bactericidal action of salts of certain rare earth metals, Ann. Med. Exp. Biol. Fenn. 36(Suppl. 6): 1–54.PubMedGoogle Scholar
  109. Muroma, A., 1959. The bactericidal action of the rare earth metals (further studies), Ann. Med. Exp. Biol. Fenn. 37(Suppl. l-7):336–340.PubMedGoogle Scholar
  110. Nagy, I., Kadas, I., and Jobst, K., 1976. Lanthanum trichloride induced blood coagulation defect and liver injury, Haematologia 10:353–359.PubMedGoogle Scholar
  111. Nappee, J., Bobrie, J., and Lombard, D., 1972. Pneumoconiosis au cérium, Arch. Mal. Prof. Med. Trav. Sec. Soc. 33:13–18.Google Scholar
  112. Neubert, D., and Hoffmeister, I., 1960. Intracellular Lokalisation von Fettsubstanzen bei experimenteller Leberverfettong, Nannyn-Schmiedeberg’s Arch. Exp. Pathol. Pharmacol. 237:519–537.Google Scholar
  113. Niccolini, P. M., 1930. Contributo allo studio farmacologico delle terre rare—il praseodimio, Arch. Int. Pharmacodyn. Ther. 37:199–240.Google Scholar
  114. Niccolini, P.M., 1931. Contributo allo studio farmacologico delle terre rare—il samario, Arch. Int. Pharmacodyn. Ther. 40:247–291.Google Scholar
  115. Novello, F., and Stirpe, F., 1969. The effects of copper and other ions on the ribonucleic acid polymerase activity of rat liver nuclei, Biochem. J. 111:115–119.PubMedCentralPubMedGoogle Scholar
  116. Oberdisse, E., Rohling, G., Losert, W., Schurig, R., and Oberdisse, U., 1973. Influence of rare earths on insulin secretion in rats, Naunyn-Schmiedeberg’s Arch. Pharmacol. 280: 217–221.Google Scholar
  117. Oberdisse, E., Winkler, R., Grajewski, O., Von Lehmann, B., and Arntz, H.R., 1974. Pharmakologische Untersuchungen zum Mechanismus der Praseodym—ausgelosten Leberschadigung, Verh. Dtsch. Ges. Inn. Med. 80:1556–1558.PubMedGoogle Scholar
  118. Oberdisse, E., Arvela, P., and Gross, U., 1979. Lanthanon-induced hepatotoxicity and its prevention by pretreatment with the same lanthanon, Arch. Toxicol. 43:105–114.PubMedGoogle Scholar
  119. Oga, S., 1971. Actividade teratogenica do cloreto de iterbioem embrião de galinha, Rev. Farm. Bioquim. Univ. São Paulo 9:327–341.PubMedGoogle Scholar
  120. Ojemann, R.G., Brownell, G.I., and Sweet, W.H., 1961. Possible radiation therapy of cephalic neoplasms by perfusion of short-lived isotopes. II. Dysprosium-165 metabolism in mouse and cat, Neurochirurgica 4:41–57.Google Scholar
  121. Palmer, R. J., Buterhoff, J. L., and Stevens, J. B., 1987. Cytotoxicity of the rare earth metals cerium, lanthanum, and neodymium in vitro: comparisons with cadmium in a pulmonary macrophage primary culture system, Environ. Res. 43:142–156.PubMedGoogle Scholar
  122. Pederson, L. A., and Libby, W. F., 1972. Unseparated rare earth-cobalt oxides as auto exhaust catalysts, Science 176:1355–1356.Google Scholar
  123. Pickard, B.G., 1970. Comparison of calcium and lanthanum ions in the Avena-coleoptile growth test, Planta 90:314–320.Google Scholar
  124. Ranganayaki, S., Bahadur, K., and Mohan, C., 1981. Microbial fixation of nitrogen in the presence of lanthanum sulphate, Z. All. Mik. 21:329–332.Google Scholar
  125. Rapaport, M.J., 1982. Depigmentation with cerium oxide, Contact Dermatitis 8:282–283.PubMedGoogle Scholar
  126. Reddy, S. V. R., and Yaksh, T. L., 1980. Antinociceptive effects of lanthanum, neodymium and europium following intrathecal administration, Neuropharmacology 19:181–185.PubMedGoogle Scholar
  127. Renaud, G., Soler-Argilaga, C., and Infante, R., 1980a. Effect of cerium on liver lipids metabolism and plasma lipoproteins synthesis in the rat, Biochem. Biophys. Res. Commun. 95:220–227.PubMedGoogle Scholar
  128. Renaud, G., Soler-Argilaga, C., Rey, C., and Infante, R., 1980b. Free fatty acid mobilization in the development of cerium-induced fatty liver, Biochem. Biophys. Res. Commun. 92:374–380.PubMedGoogle Scholar
  129. Robinson, G. A., Wasnidge, D.C., and Floto, F., 1978. Distribution of 140La and 47Ca in female Japanese quail and in the eggs laid, Poultry Sci. 57:190–196.Google Scholar
  130. Robinson, G. A., Wasnidge, D.C., and Floto, F., 1980. Radiolanthanides as markers for vitellogenin-derived proteins in the growing oocytes of Japanese quail, Poultry Sci. 59: 2312–2321.Google Scholar
  131. Rohling, G., 1974. Enfluss von Praseodym auf den Kohlenhydratstoffwechsel und die Insulinsekretion, Thesis, Freie Universität Berlin, cited in Arvela (1979).Google Scholar
  132. Rosenfeld, J. P., and Hammer, M., 1983. Antagonism of opiate-like, lanthanum-induced analgesia by naloxone, 12 mg/kg, in rats, Brain Res. 268:189–191.PubMedGoogle Scholar
  133. Saffer, L.D., Rodeheaver, G.T., Hiebert, J.M., and Edlick, R.F., 1980. In vivo and in vitro antimicrobial activity of silver sulfadiazine and cerium nitrate, Surg. Gynecol. Obstet. 151:232–236.PubMedGoogle Scholar
  134. Salas, M., and Tuchweber, B., 1976. Prevention by steroids of cerium hepatotoxicity, Arch. Toxicol. 35:115–125.PubMedGoogle Scholar
  135. Salas, M., Tuchweber, B., Kovacs, K., and Garg, B. D., 1976. Effect of cerium on the rat liver. An ultrastructural and biochemical study, Beitr. Pathol. Biol. 157:23–44.Google Scholar
  136. Sanna, A., Mascia, A., Pani, P., and Congiu, L., 1976. Protection by cerium chloride on CCl4-induced hepatotoxicity, Experientia 32:91–92.PubMedGoogle Scholar
  137. Santos, M.C., Azevedo, M. D., and Jacobsohn, K., 1982. Effect of Eu3+ on lipid biosynthesis in rat liver, Biochimie 64:305–308.PubMedGoogle Scholar
  138. Sarkadi, B., Szasz, I., Gerloczy, A., and Grardos, G., 1977. Transport parameters and stoichiometry of active calcium ion extrusion in intact human red cells, Biochim. Biophys. Acta 464:93–107.PubMedGoogle Scholar
  139. Sarkander, H.I., and Brade, W.P., 1976. On the mechanism of lanthanide-induced liver toxicity, Arch. Toxicol. 36:1–17.PubMedGoogle Scholar
  140. Sarnat, A. E., 1983. The efficiency of cobalt samarium (Co 5 Sm) magnets as retention units for overdentures, J. Dent. 11:324–333.PubMedGoogle Scholar
  141. Sartory, A., and Bailly, P., 1922. Influence des sels de terres rares sur la structure du mycélium de l’Aspergillus fumigatus Fr. et sur la formation de l’appareil conidier, C. R. Soc. Biol. 86:601–604.Google Scholar
  142. Schepers, G.W. H., 1955a. The biological action of rare earths: I. The experimental pulmonary histopathology produced by a blend having a relatively high oxide content, A.M.A. Arch. Ind. Health 12:301–305.Google Scholar
  143. Schepers, G. W. H., 1955b. The biological action of rare earths: II. The experimental pulmonary histopathology produced by a blend having a relatively high fluoride content, A.M.A. Arch. Ind. Health 12:306–316.Google Scholar
  144. Schepers, G. W. H., Delahart, A. B., and Redlin, A. J., 1955. An experimental study of the effects of rare earths on animal lungs, Arch. Ind. Health 12:297–316.Google Scholar
  145. Schimmel, R. J., 1978. Calcium antagonists and lipolysis in isolated rat epididymal adipocytes: effects of tetracaine, manganese, cobaltous and lanthanum ions and D600, Horm. Metab. Res. 10:128–134.PubMedGoogle Scholar
  146. Schmantz, E., 1964. Geschlechtsabhangigkeit der Verteilung von Radiocer kei der Ratte, Strahlentherapie 123:267–278.Google Scholar
  147. Schorderet-Slatkine, S., Schorderet, M., and Bailieu, E.-E., 1976. Initiation of meiotic maturation in Xenopus laevis oocytes by lanthanum, Nature 262:289.PubMedGoogle Scholar
  148. Schroeder, H.A., and Mitchener, M., 1971. Scandium, chromium(VI), gallium, yttrium, rhodium, palladium, indium in mice: effects on growth and lifespan, J. Nutr. 101: 1431–1438.PubMedGoogle Scholar
  149. Schurig, R., and Oberdisse, E., 1972. The influence of rare earths on hepatic gluconeogen-esis, Naunyn-Schmiedeberg’s Arch. Pharmacol. 275:419–433.Google Scholar
  150. Sedmak, J. J., MacDonald, H.S., and Kushnaryov, V.M., 1986. Lanthanide ion enhancement of interferon binding to cells, Biochem. Biophys. Res. Commum. 137:480–485.Google Scholar
  151. Seltzer, S. E., Adams, D. F., Davis, M. A., Hessel, S. J., Hevron, A., Judy, P. F., Hurlburt, A. J., and Hollenbert, N. K., 1981. Hepatic contrast agents for CT: high atomic number contrast material, J. Comput. Assist. Tomogr. 5:370–374.PubMedGoogle Scholar
  152. Selye, H., 1962. Calciphylaxis, University of Chicago Press, Chicago, p. 311.Google Scholar
  153. Selye, H., Szabo, S., Tuchweber, B., and Lefebvre, F., 1972. Acute miliary necrosis resembling reliosis hepatis produced by the combination of glucocorticoid and gadolinium, Proc. Soc. Exp. Biol. Med. 139:887–889.PubMedGoogle Scholar
  154. Sharma, S.N., Chatterjee, S.M., and Kamboj, V.P., 1973. Sterilization of male goats by formaldehyde and some metallic salts, Indian J. Exp. Biol. 11:143–148.PubMedGoogle Scholar
  155. Shearer, C., 1922. Studies of the action of electrolytes on bacteria, J. Hyg. 21:77–86.PubMedCentralPubMedGoogle Scholar
  156. Shelley, W.B., Hurley, H.J., Mayock, R.L., Close, H.P., and Cathcart, R.T., 1958. Intradermal tests with metals and other inorganic elements in saracoidosis and anthraco-silicosis, J. Invest. Dermatol. 31:301–303.PubMedGoogle Scholar
  157. Sievers, R.E., and Sadlowski, J.E., 1978. Volatile metal complexes. Certain chelates are useful as fuel additives, as metal vapor sources and in trace metal analysis, Science 201:217–223.PubMedGoogle Scholar
  158. Sihvonen, M. L., 1972. Accumulation of yttrium and lanthanoids in human and rat tissues as shown by mass spectrometric analysis and some experiments with rats, Ann. Acad. Sci. Fenn. Ser. A 168:1–62.Google Scholar
  159. Smith, B. M., Gindhart, T. D., and Colburn, N. H., 1986. Possible involvement of a lanthanide-sensitive protein kinase C substrate in lanthanide promotion of neoplastic transformation, Carcinogenesis 7:1949–1956.PubMedGoogle Scholar
  160. Snyder, F., and Kyker, G. C., 1964. Triglyceride accumulation and release in the rare-earth fatty liver, Proc. Soc. Exp. Biol. Med. 116:890–893.PubMedGoogle Scholar
  161. Snyder, F., and Stephens, N., 1961. Plasma free fatty acids and the rare-earth fatty liver, Proc. Soc. Exp. Biol. Med. 106:202–204.Google Scholar
  162. Snyder, F., Cress, E. A., and Kyker, G.C., 1959. Liver lipid response to intravenous rare earths in rats, J. Lipid Res. 1:125–131.Google Scholar
  163. Snyder, F., Cress, E.A., and Kyker, G.C., 1960a. Rare-earth fatty liver, Nature 185: 480–481.Google Scholar
  164. Snyder, F., Baker, F., Rafter, J., and Kyker, G.C., 1960b. Octanoate oxidation in the cerium-induced fatty liver, Biochim. Biophys. Acta 43:554–555.Google Scholar
  165. Sobek, J. M., and Talburt, D. E., 1968. Effect of the rare earth cerium on Escherichia coli, J.Bacteriol. 95:47–51.Google Scholar
  166. Steffee, C.H., 1959. Histopathologic effects of rare earths administered intraperitioneally to rats. A preliminary report, A.M.A. Arch. Ind. Health 20:414–419.Google Scholar
  167. Steidle, H., and Ding, M., 1929. Beitrage zur Pharmakologie der Seltenen Erdmetalle. II. Mittelung Uber das Yttrium, Naunyn-Schmiedeberg’s Arch. Exp. Pathol. Pharmacol. 141:273–279.Google Scholar
  168. Stineman, C.H., Massaro, E.J., Lown, B.A., Morganti, J. B., and Al-Hakeeb, S., 1978. Cerium tissue/organ distribution and alterations in open field and exploratory behavior following acute exposure of the mouse to cerium (citrate), J. Environ. Pathol. Toxicol. 2:553–570.PubMedGoogle Scholar
  169. Strubelt, O., Siegers, C.P., and Younes, M., 1980. The influence of silybin on the hepatotoxic and hypoglycemic effects of praseodymium and other lanthanides, Arzneim.- Forsch. 30:1690–1694.Google Scholar
  170. Swanson, A. A., and Truesdale, A. W., 1971. Elemental analysis in normal and cataractous human lens tissue, Biochem. Biophys. Res. Commun. 45:1488–1496.PubMedGoogle Scholar
  171. Talbot, R. B., Davison, F. C., Green, J. W., Reece, W. O., and Vangelder, G., 1965a. Effects of subcutaneous injection of rare earth metals, United States Atomic Energy Department Report 1170.Google Scholar
  172. Talbot, R. B., Davison, F. C., and Reece, W. O., 1965b. Inhalation exposure of mice to an aerosol of gadolinium oxide, U.S. Atomic Energy Commission Report COO-1170–6.Google Scholar
  173. Talburt, D. E., and Johnson, G.T., 1967. Some effects of rare earth elements and yttrium on microbial growth, Mycologia 59:492–503.Google Scholar
  174. Tandon, S.K., Gaur, J. S., Behari, J., Mathur, A. K., and Singh, G.B., 1977. Effects of monazite on body organs of rats, Environ. Res. 13:347–357.PubMedGoogle Scholar
  175. Tang, X., and Li, G., 1983. Effect of cerium on growth of corn seedling and its enzyme pattern, J. Chin. Rare Earth Soc. 1:56–59.Google Scholar
  176. Tapia, R., 1982. Antagonism of the ruthenium red-induced paralysis in mice by 4-amino-pyridine, guanidine and lanthanum, Neurosci. Lett. 30:73–77.PubMedGoogle Scholar
  177. Trnovec, T., Pleskova, A., and Chorvat, D., 1974. The effect of carbon tetrachloride on radiocerium metabolism in rats, Strahlentherapie 147:521–530.PubMedGoogle Scholar
  178. Tuchweber, B., and Gabbiani, G., 1967. Effect of sodium pyrophosphate on experimental soft tissue calcification and hypercalcemia, Can. J. Physiol. Pharmacol. 45:957–964.PubMedGoogle Scholar
  179. Tuchweber, B., and Savoie, L., 1968. Rare earth metals and soft-tissue calcification, Proc. Soc. Exp. Biol. Med. 128:473–476.PubMedGoogle Scholar
  180. Tuchweber, B., Trost, R., Salas, M., and Sieck, W., 1976a. Effect of praseodymium nitrate on hepatocytes and Kupffer cells in the rat, Can. J. Physiol. Pharmacol. 54:898–906.PubMedGoogle Scholar
  181. Tuchweber, B., Trost, W., Salas, M., and Sieck, R., 1976b. Prevention of praseodymium-induced hepatotoxicity by silybin, Toxicol. Appl. Pharmacol. 38:559–570.PubMedGoogle Scholar
  182. Venugopal, B., and Luckey, T. D., 1978. Metal Toxicity in Mammals, Vol. 2, Chemical Toxicity of Metals and Metalloids, Plenum Press, New York, Chapter 3, pp. 101–173.Google Scholar
  183. Vincke, E., and Oelkers, H. A., 1938. Zur Pharmakologie der Selterer Erder: Toxizitat und Wirkung auf Stoffwechsel vorgange, Arch. Exp. Path. Pharmakol. 188:465–476.Google Scholar
  184. Vincke, E., 1942. Die blutgerinnungshemmende Wirkung der seltenen Erden, Hoppe-Seyler’s Z. Physiol. Chem. 272:65–80.Google Scholar
  185. Vocaturo, G., Colombo, F., Zanoni, M., Rodi, F., Sabbioni, E., and Pietra, R., 1983. Human exposure to heavy metals. Rare earth pneumoconiosis in occupational workers, Chest 83:780–783.PubMedGoogle Scholar
  186. Von Lehmann, B., Oberdisse, E., Grajewski, O., and Arntz, H.R., 1975. Subcellular distribution of phospholipids during liver damage induced by rare earths, Arch. Toxicol. 34:89–101.PubMedGoogle Scholar
  187. Von Lehmann, B., Arvela, P., Grajewski, O., and Oberdisse, E., 1976. Drug metabolizing enzymes in the rough and smooth endoplasmic reticulum during liver damage induced by rare earths, Naunyn-Schmiedeberg’s Arch. Pharmacol. 293(Suppl. 1):R59.Google Scholar
  188. Weinmann, H.-J., Brasch, R.C., Press, W. R., and Wesbey, G. E., 1984. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent, Am. J. Radiol. 142:619–624.Google Scholar
  189. Whittingham, D. B., 1980. Parthenogenesis in mammals, in Oxford Review of Reproductive Biology (C. E. Finn, ed.), Vol. 2, Clarendon Press, Oxford, pp. 205–210.Google Scholar
  190. Wurm, M., 1951. The effect of lanthanum on growth and metabolism of Streptococcus faecalis R., J. Biol. Chem. 192:707–714.PubMedGoogle Scholar
  191. Zanni, A.C., 1965. Contribution to the pharmacology of europium, Rev. Fac. Farm. Bioquim. 3:199–240.Google Scholar
  192. Zimakov, Yu. A., 1973. Cited in Haley (1979).Google Scholar

Copyright information

© Springer Science+Business Media New York 1990

Authors and Affiliations

  • C. H. Evans
    • 1
  1. 1.The Ferguson LaboratoryUniversity of PittsburghPittsburghUSA

Personalised recommendations